Accessibility Tools
With an industry that is constantly changing and evolving, the Myonex team can be your trusted source to identify the right solutions for your projects from clinical to commercial stages. Stay up to date with our latest company news announcements.
Myonex updates
Myonex Unveils Enhanced Services for a Simplified Experience
Announcement
Myonex’s Journey on Molecule to Market
Drug sourcing
Adalvo and Myonex strengthen existing exclusive clinical trial supply partnership by adding multiple new assets for global markets
EY Announces James Lovett and Mike Cohen of Myonex as an Entrepreneur Of The Year® 2024 Greater Philadelphia Award Winner
Myonex Closes Creapharm Acquisition Expanding Global Services
Myonex Announces Acquisition Of Saveway Compounding Pharmacy To Expand Its Clinical Trial Services Across The Us
Myonex To Acquire Creapharm’s Clinical & Commercial Packaging And Bioservices Business
Authorized As A Pharmaceutical Company By French Regulatory Authorities (Ansm), Creapharm Bioservices Expands Its Scope To Include Advanced Therapy Medicinal Products
DELPHARM & CREAPHARM announced they have successfully joined forces to better serve HMNC Brain Health and met the FPI deadline in its BH-200-03 European phase 2 clinical trial.
Ancillary supply
Myonex featured in ACT: Overcoming Challenges Associated with Ancillary Supply Management
Myonex Awarded as “Top Workplace in the Philadelphia Region” for The Second Year in a Row
Biobanking
The French-speaking Diabetes Society is seeking the expertise of three leaders in the French biobanking ecosystem to accelerate the identification of new factors associated with major cardiovascular events (MACE*) in patients.